Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT)
dysfunction need sequential pulmonary valve replacements throughout their life in the majority of
cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations
(PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven
safe and effective, but some anatomical variations can limit procedural success. This review discusses
the current status and future perspectives of the procedure.
Keywords: congenital heart disease, right ventricular outflow tract dysfunction, percutaneous pulmonary valve implantation, transcatheter pulmonary valve replacement, Melody, Sapien.
Rights & PermissionsPrintExport